Oligonucleotides Targeting DNA Repeats Downregulate Huntingtin Gene Expression in Huntington's Patient-Derived Neural Model System.

Nucleic Acid Therapeutics
Tea UmekRula Zain

Abstract

Huntington's disease (HD) is one of the most common, dominantly inherited neurodegenerative disorders. It affects the striatum, cerebral cortex, and other subcortical structures leading to involuntary movement abnormalities, emotional disturbances, and cognitive impairments. HD is caused by a CAG•CTG trinucleotide-repeat expansion in exon 1 of the huntingtin (HTT) gene leading to the formation of mutant HTT (mtHTT) protein aggregates. Besides the toxicity of the mutated protein, there is also evidence that mtHTT transcripts contribute to the disease. Thus, the reduction of both mutated mRNA and protein would be most beneficial as a treatment. Previously, we designed a novel anti-gene oligonucleotide (AGO)-based strategy directly targeting the HTT trinucleotide-repeats in DNA and reported downregulation of mRNA and protein in HD patient fibroblasts. In this study, we differentiate HD patient-derived induced pluripotent stem cells to investigate the efficacy of the AGO, a DNA/Locked Nucleic Acid mixmer with phosphorothioate backbone, to modulate HTT transcription during neural in vitro development. For the first time, we demonstrate downregulation of HTT mRNA following both naked and magnetofected delivery into neural stem cells ...Continue Reading

References

Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·L A YakubovV V Vlassov
Sep 1, 1988·Journal of Neuropathology and Experimental Neurology·S M de la MonteE P Richardson
Jan 1, 1994·Applied and Environmental Microbiology·F J van KuppeveldW J Melchers
Jun 8, 2000·Developmental Dynamics : an Official Publication of the American Association of Anatomists·G Hauptmann, T Gerster
Mar 10, 2001·Nucleic Acids Research·T A VickersS M Freier
Feb 23, 2002·Science·Robert J McEvillyMichael G Rosenfeld
Aug 9, 2002·Neuroreport·Michio SugitaniNorihiko Onoda
Oct 31, 2003·Expert Reviews in Molecular Medicine·David C Rubinsztein, Jenny Carmichael
Oct 21, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Miguel Díaz-HernándezJosé J Lucas
Jul 31, 2007·Journal of Medical Genetics·V C WheelerUNKNOWN US-Venezuela Collaborative Research Group
Nov 22, 2007·Science·Junying YuJames A Thomson
Dec 15, 2007·Nature Protocols·Thomas BuerliChristian Fuhrer
Apr 9, 2008·Proceedings of the National Academy of Sciences of the United States of America·Marius WernigRudolf Jaenisch
Jun 28, 2008·Cellular Signalling·Perla Kaliman, Esther Llagostera
Dec 23, 2008·Nature·Allison D EbertClive N Svendsen
Feb 26, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ryan L BoudreauBeverly L Davidson
Sep 9, 2011·Human Molecular Genetics·Takuya YagiNorihiro Suzuki
Oct 28, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jodi L McBrideBeverly L Davidson
Jan 19, 2012·Brain : a Journal of Neurology·Richard GrondinWilliam F Kaemmerer
Jun 30, 2012·Nature Methods·Johannes SchindelinAlbert Cardona
Jan 18, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Boxun Lu, James Palacino
Apr 15, 2014·Brain Research·Iddo Magen, Eran Hornstein

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
transfect
PCR
confocal microscopy
Protein Assay
electrophoresis

Software Mentioned

Fiji
ZEN Lite
ImageJ
GraphPad Prism

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Related Papers

Journal of Huntington's Disease
Morgane Sonia Thion, Sandrine Humbert
Journal of Huntington's Disease
Sarah B Thomson, Blair R Leavitt
© 2021 Meta ULC. All rights reserved